Merkin Family Foundation

The Merkin Family Foundation functions as one of Southern California's most consequential private philanthropies — $228.6M in assets, $11–17M in annual grants, and an unwavering commitment to catalytic, institution-building gifts. This is not a foundation that takes cold applications. The foundation is explicitly preselection-only, with no public submission portal, no stated RFP cycle, and no published application guidelines.

The giving philosophy reflects the worldview of founder Richard N. Merkin, MD — a physician, entrepreneur, and CEO of Heritage Group, one of the nation's largest physician-owned integrated healthcare systems operating across California, Arizona, and New York. Merkin backs institutions and people he knows and trusts, typically over long time horizons. The Broad Institute has received $16.25M across four grants; Caltech, $16.06M across four grants; Johns Hopkins, $10M across three. These are sustained partnerships built through shared intellectual priorities, personal relationships, and demonstrated research impact — not responses to solicitations.

For biomedical research organizations, the realistic pathway is institutional access. Centers aligned with translational medicine, neural regeneration, CRISPR gene editing, cancer biology, and healthcare delivery innovation sit squarely in the foundation's wheelhouse. The establishment of the Richard N. Merkin Prize in Biomedical Technology — administered through the Broad Institute and chaired by Nobel Laureate Harold Varmus — underscores that the foundation prefers to route transformative funding through high-prestige institutions with rigorous scientific infrastructure.

A secondary giving tier operates at the Los Angeles community level. LACMA ($500K total across 4 grants), Los Angeles Ballet ($100K total across 4 grants), Boys & Girls Club ($50K), Alliance for College Ready Public Schools ($25K), and United Friends of the Children ($40K across 2 grants) reflect a founder deeply engaged with the LA civic community. These grants — ranging from $10,000 to $100,000 — are reachable via Los Angeles board networks, civic organizations, and introductions through intermediaries where Merkin is active, including Heritage Group, LA arts institutions, and charter school networks.

The most direct public entry point for biomedical organizations is the Merkin Prize nomination process (merkinprize@broadinstitute.org), with the 2027 cycle opening in August 2026. For organizations outside this prize track, the strategic path requires identifying shared board members, academic collaborators, or alumni networks connecting to Caltech, Broad Institute, Johns Hopkins, or Heritage Group leadership.

The foundation's giving history reveals a distinctly bimodal pattern that grant seekers must understand before approaching. Across 58 documented grants totaling $53.4M, the average grant is $921,500 — but the median is just $100,000. That gap tells the story: a small number of transformative, multi-million-dollar institutional gifts sit atop a broader base of community-level support.

The flagship institutional relationships command the budget. Broad Institute ($16.25M, 4 grants) and Caltech ($16.06M, 4 grants) together account for 60% of all documented giving. Johns Hopkins ($10M, 3 grants) adds another 19%. These three institutions alone represent nearly 80% of total recorded grant dollars. The documented grant size range runs from $10,000 (California State University LA, single grant) to an estimated $7M for individual flagship gifts at the top end.

Annual giving has been consistent: $11.7M in grants paid in both FY2021 and FY2022, with total giving (including pass-throughs) of $13.1M (2021) and $12.3M (2022–2023). FY2020 spiked to $18.9M ($17.2M in grants paid) — likely reflecting simultaneous recording of multi-year pledges — before returning to the $11–13M range. Going back further, giving was $6.5M in FY2018, suggesting a step-change expansion of ambition and assets between 2018 and 2019.

By program area, medical research and translational science dominates, representing approximately 53% of total documented giving. Education (higher education and K-12 combined) accounts for roughly 44%. Arts and culture receive about 1.1% — meaningful for LA cultural institutions but clearly a secondary priority. Telehealth and healthcare access innovation (The Maven Project $300K, BioScience LA $500K) constitute an emerging priority area at roughly 1.6% of total giving.

Geographic concentration is California-heavy: 83% of grants by count flow to CA-based institutions. Massachusetts (4 grants, Broad Institute) and Maryland (3 grants, Johns Hopkins) are the only meaningful exceptions — both top-tier research university relationships. The foundation's giving geography follows talent and scientific excellence rather than proximity.

The foundation's $228.6M asset base places it well within the top 5% of U.S. private foundations by size, yet it operates with far less public visibility than its capitalization would suggest.

Among these similarly capitalized peers, Merkin stands out for two reasons. First, it is one of the few in this cohort to maintain a public-facing programmatic identity (the Merkin Prize, administered via Broad Institute), which creates a defined, accessible entry point for biomedical researchers despite the invitation-only grantmaking model. Second, its sustained, multi-grant commitments to elite research universities — averaging over $4M per institutional relationship across multiple cycles — reflect a deeper endowment-building philosophy than typical family philanthropy at this asset level. Grant seekers evaluating this peer set should expect all five foundations to be highly selective, relationship-driven funders with minimal or no public application infrastructure.

The most significant development in the Merkin Family Foundation's recent ecosystem is the full launch and maturation of the Richard N. Merkin Prize in Biomedical Technology, administered through the Broad Institute and chaired by Nobel Laureate Harold Varmus. The prize — first awarded in 2023 — recognizes pathbreaking technologies demonstrably improving human health through treatment, diagnosis, or prevention of disease. Nominations for the 2026 cycle closed in early 2026; the 2027 cycle opens in August 2026 (contact: merkinprize@broadinstitute.org).

On the research center side, the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins Medicine held its third annual hybrid symposium in March 2025, drawing 143 attendees from 38 institutions worldwide — an 85% attendance increase over its three-year history. A fourth symposium is planned for 2026. A related event on November 15, 2024 at Bloomberg Center in Washington, D.C. marked the launch of the center's cross-country E-Bike Tour campaign and premiere of a documentary about the initiative.

No leadership changes at the foundation are apparent in recent 990 filings — Richard Merkin continues as President and Anne Wymer as Secretary/Treasurer, both receiving no compensation. Web research found no publicly announced new grant programs or open RFP cycles as of March 2026. Total assets have remained remarkably stable at approximately $228–241M across FY2019–2023, reflecting consistent investment returns and disciplined grantmaking.

This foundation does not respond to unsolicited proposals. The application_instructions field in public records is explicitly marked as none, and there is no grants portal, downloadable application, or published submission deadline. Understanding this reality is the essential first step.

That said, specific, actionable pathways exist for qualified organizations:

For biomedical researchers and medical research institutions: - The Merkin Prize is the primary public interface for the foundation's scientific philanthropy. Nominations for the 2027 cycle open August 2026 via merkinprize@broadinstitute.org. Organizations and researchers working on translational technologies — specifically CRISPR gene editing, neural regeneration, cancer diagnostics, and healthcare delivery innovation — should position their work within the prize nomination framework and join the mailing list at merkinprize.org. - Institutions with existing relationships at Broad Institute, Caltech, or Johns Hopkins should explore whether shared leadership or advisory board relationships can generate a warm introduction. Merkin is personally invested in these institutions as documented by decades of sustained giving. - Align positioning language with Merkin's documented priorities: 'translational research,' 'demonstrably improving human health,' 'novel technologies,' and 'next generation of scientists.' These phrases appear directly in foundation communications and prize criteria. - The Schaeffer Center for Health Policy ($100K) and The Maven Project ($300K telehealth) suggest emerging interest in healthcare access and policy innovation — organizations in this space may find alignment beyond pure bench science.

For Los Angeles-area community organizations (education, arts, youth services): - Grants to LA organizations range from $10,000 to $125,000 per grant, suggesting these are relationship maintenance gifts rather than competitive awards. Entry requires introduction through the LA civic community — LACMA, LA Ballet, Alliance for College Ready Public Schools, and Heritage Group's community presence are the highest-probability networks. - Timing: Approach in September–November, when foundations typically finalize giving calendars for the following year. - Past grantees in the LA community tier include youth-serving organizations (United Friends of the Children at $20K/grant, Boys & Girls Club at $50K) and arts institutions (LACMA at $125K/grant avg, LA Ballet at $25K/grant avg). Size your ask accordingly.

What to avoid: Cold mail inquiries to the residential address have no realistic path to review. Generic grant proposals — without specific intellectual or programmatic alignment to Merkin's documented interests — will not resonate. Do not submit a full proposal without a prior relationship or warm introduction.